Company intelligence / Profile preview

Guangzhou Bairui Medicine

Guangzhou, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Guangzhou Bairui Medicine is a Chinese pharmaceutical company focused on the R&D, manufacturing, and sales of plant extracts, medicinal intermediates, and raw materials, including active pharmaceutical ingredients (APIs) such as imatinib mesylate, hydrocortisone sodium succinate, and antibiotic APIs. Products are commercial and available as raw ingredients, not as branded finished drugs.

Modalities: Small molecule
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Guangzhou Bairui Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangzhou Bairui Medicine.

Explore the full profile